PCM
BIOL
Perkins Capital Management’s Biolase, Inc. BIOL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-157,196
| Closed | -$11K | – | 99 |
|
|
2023
Q2 | $11K | Sell |
157,196
-2,566,285
| -94% | -$180K | 0.01% | 94 |
|
|
2023
Q1 | $766K | Buy |
2,723,481
+2,677,285
| +5,795% | +$753K | 0.72% | 46 |
|
|
2022
Q4 | $30K | Sell |
46,196
-85,874
| -65% | -$55.8K | 0.03% | 95 |
|
|
2022
Q3 | $321K | Buy |
132,070
+13,770
| +12% | +$33.5K | 0.36% | 69 |
|
|
2022
Q2 | $542K | Sell |
118,300
-2,947,730
| -96% | -$13.5M | 0.56% | 53 |
|
|
2022
Q1 | $1.08M | Buy |
3,066,030
+19,000
| +0.6% | +$6.71K | 0.89% | 44 |
|
|
2021
Q4 | $1.19M | Sell |
3,047,030
-87,070
| -3% | -$33.9K | 0.8% | 45 |
|
|
2021
Q3 | $2M | Buy |
3,134,100
+11,250
| +0.4% | +$7.19K | 1.24% | 27 |
|
|
2021
Q2 | $2.18M | Buy |
3,122,850
+1,467,350
| +89% | +$1.02M | 1.24% | 30 |
|
|
2021
Q1 | $1.4M | Buy |
1,655,500
+439,250
| +36% | +$370K | 0.81% | 44 |
|
|
2020
Q4 | $507K | Buy |
1,216,250
+105,250
| +9% | +$43.9K | 0.33% | 62 |
|
|
2020
Q3 | $306K | Buy |
+1,111,000
| New | +$306K | 0.28% | 71 |
|
|
2020
Q1 | $518K | Buy |
1,381,000
+61,900
| +5% | +$23.2K | 0.63% | 53 |
|
|
2019
Q4 | $729K | Buy |
+1,319,100
| New | +$729K | 0.65% | 52 |
|
|
2015
Q1 | – | Sell |
-322,830
| Closed | -$849K | – | 141 |
|
|
2014
Q4 | $849K | Sell |
322,830
-8,958
| -3% | -$23.6K | 0.73% | 54 |
|
|
2014
Q3 | $826K | Sell |
331,788
-5,620
| -2% | -$14K | 0.7% | 56 |
|
|
2014
Q2 | $742K | Sell |
337,408
-19,387
| -5% | -$42.6K | 0.52% | 63 |
|
|
2014
Q1 | $860K | Buy |
356,795
+167,073
| +88% | +$403K | 0.6% | 59 |
|
|
2013
Q4 | $537K | Sell |
189,722
-37,288
| -16% | -$106K | 0.36% | 86 |
|
|
2013
Q3 | $434K | Buy |
+227,010
| New | +$434K | 0.31% | 85 |
|